New Tools Support Developing Better TB Drugs

I. Gardner & O. Hatley

Tuberculosis (TB)—caused by infection with the mycobacterium Mycobacterium tuberculosis—is one of the top 10 leading causes of death worldwide with a total of 1.8 million people dying from the disease in 2015. TB is also the leading cause of death in HIV-infected individuals. TB usually attacks the lungs but can infect any part of the […]

Read More
Topics: PBPK Modeling and Simulation

Using Modeling and Simulation to Combat Tuberculosis: A Global Health Priority

June 22, 2017 – Attend this webinar with C-Path’s Dr. Klaus Romero to learn how they integrated lung and granuloma models, together with a library of drug and metabolite files, into the latest version of the Simcyp Simulator to establish a robust resource that will help development teams and regulators evaluate the safety and efficacy of novel anti-TB drug regimens.

Read More
Learn More